Related references
Note: Only part of the references are listed.Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
Liselotte M. S. Boeve et al.
EUROPEAN UROLOGY (2019)
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies
Gwenaelle Gravis et al.
EUROPEAN UROLOGY (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Sean P. Pitroda et al.
NATURE COMMUNICATIONS (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis
Bjorn Loppenberg et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
Anwar R. Padhani et al.
EUROPEAN UROLOGY (2017)
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer
Elise De Bleser et al.
CURRENT OPINION IN UROLOGY (2017)
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Noura Radwan et al.
BMC CANCER (2017)
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
Chad G. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease
Matthew D. Blackledge et al.
PLOS ONE (2016)
Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients
Xiaobin Gu et al.
SCIENTIFIC REPORTS (2016)
Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells
A. Formosa et al.
ONCOGENE (2014)
Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases
Ulrike Schick et al.
ACTA ONCOLOGICA (2013)
Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
Patrick Berkovic et al.
CLINICAL GENITOURINARY CANCER (2013)
Stereotactic body radiotherapy for oligometastases
Alison C. Tree et al.
LANCET ONCOLOGY (2013)
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer
Alexander Muacevic et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
Kamran A. Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
Salvage Lymph Node Dissection with Adjuvant Radiotherapy for Nodal Recurrence of Prostate Cancer
C. A. Jilg et al.
JOURNAL OF UROLOGY (2012)
PSA velocity and doubling time in diagnosis and prognosis of prostate cancer
Andrew J. Vickers et al.
JOURNAL OF CLINICAL UROLOGY (2012)
Oligometastases revisited
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Quality of life three years after diagnosis of localised prostate cancer: population based cohort study
David P. Smith et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Design issues of randomized phase II trials and a proposal for phase II screening trials
LV Rubinstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
